SEC Filings for Annovis Bio Inc. (ANVS)

$ 3.05 r      0.55 (+22.00%) Volume: 9.79k 1:04 PM EDT Apr 3, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)304/03/2020
10-KAnnual report pursuant to Section 13 or 15(d)14703/25/2020
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans902/14/2020
8-KCurrent report pursuant to Section 13 or 15(d)3502/06/2020
4Statement of changes in beneficial ownership of securities102/05/2020
4Statement of changes in beneficial ownership of securities102/05/2020
4Statement of changes in beneficial ownership of securities102/05/2020
4Statement of changes in beneficial ownership of securities102/05/2020
4Statement of changes in beneficial ownership of securities102/05/2020
4Statement of changes in beneficial ownership of securities102/05/2020
SC 13GStatement of acquisition of beneficial ownership by individuals701/30/2020
3Initial statement of beneficial ownership of securities101/29/2020
3Initial statement of beneficial ownership of securities101/29/2020
3Initial statement of beneficial ownership of securities101/29/2020
3Initial statement of beneficial ownership of securities101/29/2020
<<
First
<
Prev
123